68 related articles for article (PubMed ID: 9607110)
1. Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A.
Ill CR; Yang CQ; Bidlingmaier SM; Gonzales JN; Burns DS; Bartholomew RM; Scuderi P
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S23-30. PubMed ID: 9607110
[TBL] [Abstract][Full Text] [Related]
2. Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: modelling gene therapy for haemophilia.
Miller G; Steinbrecher RA; Murdock PJ; Tuddenham EG; Lee CA; Pasi KJ; Goldspink G
Gene Ther; 1995 Dec; 2(10):736-42. PubMed ID: 8750013
[TBL] [Abstract][Full Text] [Related]
3. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
[TBL] [Abstract][Full Text] [Related]
4. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.
Roth DA; Tawa NE; O'Brien JM; Treco DA; Selden RF;
N Engl J Med; 2001 Jun; 344(23):1735-42. PubMed ID: 11396439
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophilia.
Hough C; Kamisue S; Cameron C; Notley C; Tinlin S; Giles A; Lillicrap D
Thromb Haemost; 2002 Apr; 87(4):659-65. PubMed ID: 12008949
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary experimental research on gene therapy for hemophilia A].
Yin J; Wang H; Hu Y; Wang X; Qu B; Chu H; Duan B; Kang W; Qi Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):138-42. PubMed ID: 12015067
[TBL] [Abstract][Full Text] [Related]
8. [Construction of a human factor VIII gene-containing plasmid and its expression in Cos-7 cells].
Lu J; Jiang Z; Chen S
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):129-32. PubMed ID: 11243143
[TBL] [Abstract][Full Text] [Related]
9. A systematic study of the function of the human beta-globin introns on the expression of the human coagulation factor IX in cultured Chinese hamster ovary cells.
Haddad-Mashadrizeh A; Zomorodipour A; Izadpanah M; Sam MR; Ataei F; Sabouni F; Hosseini SJ
J Gene Med; 2009 Oct; 11(10):941-50. PubMed ID: 19565465
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
11. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
12. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery.
Wooddell CI; Reppen T; Wolff JA; Herweijer H
J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biology of human factor VIII and its production by gene engineering technique].
Sugiyama T; Tajima Y
Tanpakushitsu Kakusan Koso; 1990 Oct; 35(14):2671-87. PubMed ID: 2125133
[No Abstract] [Full Text] [Related]
14. Mutation detection in factor VIII cDNA from lymphocytes of hemophilia A patients by solid phase fluorescent chemical cleavage of mismatch.
Waseem NH; Bagnall R; Green PM; Giannelli F
Methods Mol Biol; 2002; 187():109-23. PubMed ID: 12013738
[No Abstract] [Full Text] [Related]
15. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
16. Factoring nonviral gene therapy into a cure for hemophilia A.
Gabrovsky V; Calos MP
Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922
[TBL] [Abstract][Full Text] [Related]
17. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
18. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
Doering CB
Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia treatment. Gene therapy, factor VIII antibodies and immune tolerance: hopes and concerns.
Lillicrap D
Haematologica; 2000 Oct; 85(10 Suppl):108-11; discussion 111-2. PubMed ID: 11187861
[TBL] [Abstract][Full Text] [Related]
20. Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation.
Mei WH; Qian GX; Zhang XQ; Zhang P; Lu J
Haemophilia; 2006 May; 12(3):271-9. PubMed ID: 16643213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
